Senate Vote On Adverse Event Reporting Bill Expected By October
This article was originally published in The Tan Sheet
Executive Summary
The Senate likely will vote on the "Dietary Supplement & Nonprescription Drug Consumer Protection Act" (S 3546) before they adjourn in early October, according to several supplement industry trade groups